Press MF - Search Results

1

An admixture scan in 1,484 African American women with breast cancer.

Fejerman L, Haiman CA, Reich D, Tandon A, Deo RC, John EM, Ingles SA, Ambrosone CB, Bovbjerg DH, Jandorf LH, Davis W, Ciupak G, Whittemore AS, Press MF, Ursin G, Bernstein L, Huntsman S, Henderson BE, Ziv E, Freedman ML. Fejerman L, et al. Among authors: press mf. Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3110-7. doi: 10.1158/1055-9965.EPI-09-0464. Epub 2009 Oct 20. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19843668 Free PMC article.

2

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR, Flom KJ. Press MF, et al. J Clin Oncol. 1997 Aug;15(8):2894-904. doi: 10.1200/JCO.1997.15.8.2894. J Clin Oncol. 1997. PMID: 9256133

3

Does estrogen receptor expression in normal breast tissue predict breast cancer risk?

Bernstein L, Press MF. Bernstein L, et al. Among authors: press mf. J Natl Cancer Inst. 1998 Jan 7;90(1):5-7. doi: 10.1093/jnci/90.1.5. J Natl Cancer Inst. 1998. PMID: 9428773 No abstract available.

4

Clonal analysis of bilateral breast cancer.

Shibata A, Tsai YC, Press MF, Henderson BE, Jones PA, Ross RK. Shibata A, et al. Among authors: press mf. Clin Cancer Res. 1996 Apr;2(4):743-8. Clin Cancer Res. 1996. PMID: 9816225

5

The risk of angiosarcoma following primary breast cancer.

Cozen W, Bernstein L, Wang F, Press MF, Mack TM. Cozen W, et al. Among authors: press mf. Br J Cancer. 1999 Oct;81(3):532-6. doi: 10.1038/sj.bjc.6690726. Br J Cancer. 1999. PMID: 10507781 Free PMC article.

6

Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis.

Wen WH, Bernstein L, Lescallett J, Beazer-Barclay Y, Sullivan-Halley J, White M, Press MF. Wen WH, et al. Among authors: press mf. Cancer Res. 2000 May 15;60(10):2716-22. Cancer Res. 2000. PMID: 10825146

7

Germ-line HER-2 variant and breast cancer risk by stage of disease.

McKean-Cowdin R, Kolonel LN, Press MF, Pike MC, Henderson BE. McKean-Cowdin R, et al. Among authors: press mf. Cancer Res. 2001 Dec 1;61(23):8393-4. Cancer Res. 2001. PMID: 11731415

8

The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results.

Marchbanks PA, Mcdonald JA, Wilson HG, Burnett NM, Daling JR, Bernstein L, Malone KE, Strom BL, Norman SA, Weiss LK, Liff JM, Wingo PA, Burkman RT, Folger SG, Berlin JA, Deapen DM, Ursin G, Coates RJ, Simon MS, Press MF, Spirtas R. Marchbanks PA, et al. Among authors: press mf. Ann Epidemiol. 2002 May;12(4):213-21. doi: 10.1016/s1047-2797(01)00274-5. Ann Epidemiol. 2002. PMID: 11988408

9

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens.

Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY, Bernstein L. Press MF, et al. J Clin Oncol. 2002 Jul 15;20(14):3095-105. doi: 10.1200/JCO.2002.09.094. J Clin Oncol. 2002. PMID: 12118023

10

Lifetime recreational exercise activity and risk of breast carcinoma in situ.

Patel AV, Press MF, Meeske K, Calle EE, Bernstein L. Patel AV, et al. Among authors: press mf. Cancer. 2003 Nov 15;98(10):2161-9. doi: 10.1002/cncr.11768. Cancer. 2003. PMID: 14601085 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page